Keiichi Fukuda, President and CEO of Heartseed Inc., will be speaking at the 25th World Congress of the International Society for Heart Research (ISHR), to be held from May 11 to 14, 2025, at the Nara Prefectural Convention Center in Japan.

The ISHR is a global organization with eight regional sections, dedicated to advancing and disseminating knowledge in cardiovascular science. While regional meetings are held annually, the World Congress convenes once every three years. The 2025 congress will take place in Nara and is expected to welcome more than 300 leading researchers from around the world.

Dr. Fukuda will present the latest progress in the clinical development of regenerative therapies using iPSC-derived cardiomyocyte spheroids, highlighting their potential as a new treatment for severe heart failure.

Presentation Details:

• Date & Time: May 14, 2025, 14:00-16:00

• Session: International Symposium 19
  "Current status of cardiac regeneration therapy: from preclinical study to clinical trial"

• Presentation Title:
  "Current status of human iPS cell derived cardiomyocyte transplantation to the patients with severe heart failure due to ischemic heart disease in LAPiS study"

• Venue: Nara Prefectural Convention Center, Japan

For more information and the full program, please visit the official website: https://www.ishr2025nara.jp/speakers_symposium.html